Earnings · China A-shares
Beijing SL Pharmaceutical Co. Ltd. Class A (002038) earnings
Beijing SL Pharmaceutical Co. Ltd. Class A published its Q3 report on 2026-10-28: net profit -348.15% year on year, -32.94% excluding one-off items. Wave Radar's earnings-quality score is 59 of 100 (Questionable). The stock moved -0.39% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-28
- Period end
- 2026-09-30
- Net profit YoY
- -348.15%
- Excl. one-offs YoY
- -32.94%
- Result
- Bad / loss
- Quality score
- 59
- Quality
- Questionable
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -1.57% | — |
| 3 days | -0.39% | — |
| 7 days | +1.18% | — |
| 14 days | -4.91% | — |
Report history
Over the last 8 reports, net profit grew year on year in 2 of them. The stock rose in the 3 trading days after 1 of 6 reports (average -1.99%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-29 | -¥350.13M | -348.15% | -32.94% | -14.82% | -0.34 | -6.99% | -0.39% | — | — |
| 2026 interim report | 2026-08-26 | -¥255.08M | -310.72% | -85.58% | -17.51% | -0.25 | -5.05% | -1.41% | -14.60% | -7.61% |
| 2026 Q1 report | 2026-04-29 | -¥86.11M | -287.33% | +54.62% | -18.98% | -0.08 | -1.56% | -5.27% | -21.38% | -22.32% |
| 2025 annual report | 2026-04-29 | -¥347.20M | -368.77% | — | -5.57% | -0.34 | -6.46% | -5.27% | -21.38% | -22.32% |
| 2025 Q3 report | 2025-10-27 | ¥141.10M | +943.10% | -62.39% | -15.13% | 0.14 | 2.50% | -0.53% | +5.06% | +5.29% |
| 2025 interim report | 2025-08-26 | ¥121.05M | +309.08% | -78.42% | -22.24% | 0.12 | 2.15% | -6.50% | -12.02% | -13.70% |
| 2025 Q1 report | 2025-04-22 | ¥45.97M | -34.46% | -79.19% | -31.10% | 0.04 | 0.82% | +2.15% | +8.31% | +5.44% |
| 2024 annual report | 2025-04-22 | -¥74.07M | -117.77% | -64.75% | -35.15% | -0.07 | -1.30% | +2.15% | +8.31% | +5.44% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.